0000000000121632

AUTHOR

Günter Krämer

showing 15 related works from this author

No evidence for efficacy of intrathecal verapamil in the treatment of tonic-clonic status epilepticus

1992

In two patients with refractory generalized tonic-clonic status epilepticus, 15 mg of the calcium antagonist verapamil was given by suboccipital intrathecal administration. During a 2–6-h observation period, seizure frequency did not decrease. However, in one patient, verapamil induced severe hypotension. Subsequent thiopental anesthesia suppressed convulsions immediately. Our results indicate that, in contradistinction to animal studies with different administration techniques, intrathecal administration of verapamil does not produce any anticonvulsant effect in humans.

business.industryGeneral Neurosciencemedicine.medical_treatmentAntagonistchemistry.chemical_elementStatus epilepticusPharmacologyCalciumIntrathecalTonic (physiology)AnticonvulsantchemistryAnesthesiamedicineVerapamilNeurology (clinical)Animal studiesmedicine.symptombusinessmedicine.drugJournal of Epilepsy
researchProduct

Clinical Syndromes, Pathogenesis, and Differential Diagnosis

1991

The temporal sequence of signs and symptoms in patients with cerebral ischemia provides important information for the analysis of underlying pathophysiologic mechanisms and in the search for a major hemodynamic or embolic cause. The signs reported and symptoms assessed are useful for localization of the ischemic region of the brain and identification of the affected vascular territories. Even in the case of a typical clinical picture the clinical findings alone are often insufficient for unequivocal anatomic and pathologic identification, however important they may be in the choice of diagnostic and therapeutic measures. In the first few hours after cerebral ischemia, determining the progno…

medicine.medical_specialtybusiness.industrymedicine.medical_treatmentIschemiaHemodynamicsSpontaneous remissionThrombolysisPosterior cerebral arterymedicine.diseasePathogenesismedicine.arteryInternal medicinemedicineBasilar arteryCardiologyDifferential diagnosisbusiness
researchProduct

Pathophysiology of Cerebral Ischemia

1991

The weight of the brain amounts to only 2% of total body weight, but it receives 15% of the cardiac output and uses 20% of the oxygen consumed by the body. The energy supply is provided almost exclusively by glucose metabolism. The substrate for this is stored in the brain in the form of glucose or glycogen and is sufficient to cover the energy requirements for only about 1 min. Consequently, there is a delicate equilibrium between oxygen and nutrient supply from the blood and the energy requirements of the brain. Disturbances in neurologic function appear after a few seconds of ischemia, although they are not necessarily persistent at first.

medicine.medical_specialtyCardiac outputGlycogenChemistryIschemiachemistry.chemical_elementCarbohydrate metabolismmedicine.diseaseOxygenCerebral edemachemistry.chemical_compoundEndocrinologyCerebral blood flowInternal medicinemedicineCerebral perfusion pressure
researchProduct

Magnetic resonance imaging in infections of the brain: findings in tuberculosis, listeriosis, toxoplasmosis, subacute sclerosing panencephalitis, and…

1987

A total of 6 patients with various inflammatory brain diseases were investigated by MRI. Typical diagnostic criteria like signal intensity, location, and morphology of the lesions are presented. MRI proves to be a highly sensitive method to detect encephalitic foci, which, however, suffers from a low specificity. Therefore additional informations like case history, clinical findings, and serological data have to be considered to find the correct diagnosis.

Pathologymedicine.medical_specialtyTuberculosisMultiple SclerosisSubacute sclerosing panencephalitisSerologymedicineHumansTuberculosisListeriosisChildBrain Diseasesmedicine.diagnostic_testbusiness.industryMultiple sclerosisBrainMagnetic resonance imagingGeneral Medicinemedicine.diseaseMagnetic Resonance ImagingToxoplasmosisSurgeryNeurology (clinical)NeurosurgerySubacute Sclerosing PanencephalitisbusinessEncephalitisNeurosurgical review
researchProduct

Cognitive-behavioral screening in elderly patients with new-onset epilepsy before treatment

2014

Objectives Cognitive comorbidity at epilepsy onset reflects disease severity and provides a baseline estimate of reserve capacities with regard to the effects of epilepsy and its treatment. Given the high incidence of epilepsy at an older age, this study analyzed objective and subjective cognition as well as quality of life in elderly patients with new-onset focal epilepsy before initiation of anti-epileptic treatment. Materials and methods A total of 257 untreated patients (60–95 years of age) with new-onset epilepsy underwent objective assessment of executive function (EpiTrack) and performed subjective ratings of cognition (Portland Neurotoxicity Scale) and quality of life (QoL; QOLIE-31…

MalePediatricsmedicine.medical_specialtymedia_common.quotation_subjectComorbidityExecutive FunctionEpilepsyDouble-Blind MethodmedicineHumansAgedmedia_commonAged 80 and overEpilepsyIncidenceNeuropsychologyCognitionGeneral MedicineMiddle AgedExecutive functionsmedicine.diseaseComorbidityNeurologyQuality of LifeEtiologyPhysical therapyAnticonvulsantsFemaleNeurology (clinical)Cognition DisordersPsychologyBody mass indexVigilance (psychology)Acta Neurologica Scandinavica
researchProduct

A randomized, double-blind comparison of antiepileptic drug treatment in the elderly with new-onset focal epilepsy.

2015

Objective: To compare the effectiveness of controlled-released carbamazepine (CR-CBZ) to levetiracetam (LEV) and to lamotrigine (LTG) in elderly patients with newlydiagnosedfocalepilepsy.Methods: Randomized, double-blind, parallel-group trial conducted between January2007andAugust2011,in47ambulatoryorhospitalsitesinGermany,Austria,orSwit-zerland. Eligible participants were aged ≥60, had new-onset epilepsy, had no acute ill-nessasthecauseoftheirseizures,andhadnocontraindicationtothedrugsinthetrial.Patients were randomized 1:1:1 to CR-CBZ, LTG, or LEV. Doses were up-titrated for6 weeks and could be maintained or adjusted depending on seizure relapse or tolera-bility over an additional period …

Malemedicine.medical_specialtyTime FactorsPopulationKaplan-Meier EstimateLamotrigineEpilepsyDouble-Blind MethodInternal medicinemedicineHumansLongitudinal StudiesAdverse effecteducationAgedRetrospective Studieseducation.field_of_studyDose-Response Relationship Drugbusiness.industryCarbamazepineMiddle Agedmedicine.diseaseDiscontinuationEuropeLogistic ModelsTreatment OutcomeNeurologyTolerabilityAnesthesiaAnticonvulsantsFemaleNeurology (clinical)LevetiracetamEpilepsies Partialbusinessmedicine.drugEpilepsia
researchProduct

Treatment and Prophylaxis

1991

Following a stroke, the patient’s neurologic deficit may be most impressive, but his treatment and prognosis depend largely upon accompanying systemic disorders. Acute treatment, for instance, must take into consideration such things as cardiovascular disorders (myocardial infarction, valve defects, arrhythmias, hypertension), disorders of renal function, and diabetes mellitus. The early detection and treatment of such systemic problems can help to prevent complications that would be difficult to control later. Thus, in a patient with latent heart disease hypervolemic therapy with low molecular weight dextran may in fact elicit right heart failure and pulmonary edema instead of helping the …

medicine.medical_specialtyHeart diseasebusiness.industryCerebral infarctionRenal functionmedicine.diseasePulmonary edemaLow molecular weight dextranRight heart failureDiabetes mellitusInternal medicinemedicineCardiologyMyocardial infarctionbusiness
researchProduct

Balance of T1-weighted images before and after application of a paramagnetic substance (Gd-DTPA)

1987

Ten patients with encephalitis disseminata and 10 patients with cerebral ischemia underwent computed tomography and magnetic resonance imaging examinations. The results before and after the application of contrast media were compared. It is shown that T1-weighted MRI images, even after application of gadolinium-DTPA, are of little value for differential diagnosis of these diseases. In contrast, T2-weighted images did support the diagnosis of an acute stage of encephalitis disseminata versus acute ischemia. This was also true for lesions that had not been adequately depicted by computed tomography.

AdultGadolinium DTPAMalemedicine.medical_specialtyIschemiaGadoliniumComputed tomographyDiagnosis DifferentialOrganometallic CompoundsmedicineT1 weightedHumanscardiovascular diseasesmedicine.diagnostic_testbusiness.industryMultiple sclerosisBrainMagnetic resonance imagingGeneral MedicineMiddle AgedPentetic Acidmedicine.diseaseMagnetic Resonance ImagingIschemic Attack TransientEncephalitisFemaleSurgeryNeurology (clinical)RadiologyNeurosurgeryDifferential diagnosisbusinessNuclear medicineEncephalitisNeurosurgical Review
researchProduct

Internalized myofiber capillaries: Observations on their origin and clinical features

1989

Internalized capillaries limited to type 1 muscle fibers were noted in seven patients. They occurred in each case in association with a similar admixture of neurogenic and myopathic features that included atrophic and hypertrophic fibers, internal nuclei, fiber splitting, and endomyseal and perimyseal fibrosis. Internalized capillaries in enlarged type 1 fibers arose from fiber splits on step section study of four patients. They occurred in the gastrocnemius, quadriceps, and soleus muscles from patients with a variety of disorders that included Becker dystrophy, diabetes mellitus and strenuous leg activities, Achilles tendon rupture, and myotonic dystrophy. Exercise-induced myalgias were no…

AdultMaleAdolescentPhysiologyMyotonic dystrophyMuscle hypertrophyCellular and Molecular NeuroscienceMuscular DiseasesTendon InjuriesFibrosisPhysiology (medical)HumansMyotonic DystrophyMedicineMyocyteProspective StudiesMuscular dystrophyRupturebusiness.industryMusclesAnatomyMiddle Agedmedicine.diseaseMyotoniaCapillariesDiabetes Mellitus Type 1Neurology (clinical)Achilles tendon rupturemedicine.symptombusinessPolyneuropathyMuscle & Nerve
researchProduct

Combined therapy with acyclovir and adenosine arabinoside in herpes simplex encephalitis.

1987

We report a case of herpes simplex encephalitis (HSE) with initial coma and severe left-sided hemiparesis in which combined treatment with adenine arabinoside and acyclovir was followed by complete recovery. This favorable result is discussed in view of the literature of HSE treatment including experimental studies on antiviral activity of both drugs. Combined treatment may be useful in severe cases of HSE.

Adultmedicine.medical_treatmentAcyclovirmedicineHumansAciclovirVidarabineComaChemotherapybusiness.industryHerpes Simplexmedicine.diseaseVirologyAdenosineHemiparesisNeurologyEncephalitisDrug Therapy CombinationFemaleNeurology (clinical)Viral diseasemedicine.symptombusinessTomography X-Ray ComputedEncephalitisVidarabinemedicine.drugEuropean neurology
researchProduct

Applied Anatomy of the Cerebral Arteries

1991

Four arteries supply the brain with blood: the two carotid and the two vertebral arteries. Although these four vessels are ultimately interlinked via a basal arterial network, the circle of Willis, and anastomoses at the brain surface, Heubner’s anastomoses, it is useful to distinguish anterior (carotid anterior and middle cerebral) and posterior (vertebrobasilar posterior cerebral) vascular territories (Gillian 1957, 1968; Lazorthes 1961; Kaplan and Ford 1966; Ganshirt 1972; Seeger 1978; Dorndorf 1983; Duus 1983).

business.industryVertebral arteryCerebral arteriesPosterior cerebral arteryAnatomyAnastomosisBasal (phylogenetics)medicine.arteryOphthalmic arterycardiovascular systemmedicineAnterior cerebral arterybusinessCircle of Willis
researchProduct

Epidemiology and Classification of Strokes

1991

Epidemiology concerns the occurrence and distribution of diseases in the population. By prevalence is meant the number of cases of the disease at a particular moment in a given group of persons, for example, in the entire population of a certain territory or in a clearly demarcated population group. Incidence refers to the number of new cases of the disease occurring in a population in a particular period of time. Figures on prevalence and incidence are meaningful only if the given disease is unequivocally defined. If the definition is too specific, many cases are not included (false-negative cases), whereas too broad a definition leads to many false-positive identifications (Table 3.1). Di…

medicine.medical_specialtyEntire populationeducation.field_of_studybusiness.industryDisease mortalityIncidence (epidemiology)PopulationDiseaseCerebral blood volumeMortality dataEpidemiologymedicinebusinesseducationDemography
researchProduct

Internuclear ophthalmoplegia of abduction: clinical and electrophysiological data on the existence of an abduction paresis of prenuclear origin.

1992

Three patients showed unilateral and five bilateral abduction paresis. Five had associated adduction nystagmus of the contralateral eye. Electrophysiological testing of masseter and blink reflexes indicated an ipsilateral rostral pontine or mesencephalic lesion, and excluded a lesion of the infranuclear portion of the abducens nerve. Abduction paresis was attributed to impaired inhibition of the tonic resting activity of the antagonistic medial rectus muscle. The prenuclear origin of the disorder is based on morphological and neurophysiological evidence of an ipsilateral inhibitory connection between the paramedian pontine reticular formation and the oculomotor nucleus running close to but …

Malegenetic structuresInternuclear ophthalmoplegiaFunctional LateralityOculomotor nucleusAbducens NerveOculomotor NervePonsmedicineHumansAbducens nerveParesisAgedOphthalmoplegiaBlinkingOculomotor nervebusiness.industryReticular FormationMedial rectus muscleAnatomyParamedian pontine reticular formationMiddle AgedMedial longitudinal fasciculusmedicine.diseasebody regionsElectrophysiologyPsychiatry and Mental healthElectrooculographymedicine.anatomical_structureSurgeryFemaleNeurology (clinical)medicine.symptombusinessResearch ArticleJournal of neurology, neurosurgery, and psychiatry
researchProduct

The safety and efficacy of add-on levetiracetam in elderly patients with focal epilepsy: A one-year observational study

2011

Abstract Purpose The long-term safety and efficacy of levetiracetam (LEV) was evaluated as add-on therapy in focal epilepsy patients ( n =491) aged at least 65 years who failed at least one monotherapy. Methods Patients ( n =491) with focal epilepsy treated with at least one antiepileptic drug in monotherapy with insufficient seizure control were included in this prospective open-label study. The recommended LEV dose range was 1000–3000mgperday. Follow-up visits were done approximately after 3, 6 and 12 months. Safety and efficacy was analysed based on all patients who received LEV (safety population, n =491) and all patients who were seen at all visits and completed the trial (per protocol…

MalePediatricsmedicine.medical_specialtyLevetiracetamEfficacyPopulationClinical NeurologyEpilepsyPharmacotherapyElderlySeizure controlmedicineHumanseducationAdverse effectAgedAged 80 and overeducation.field_of_studyEpilepsybusiness.industryGeneral Medicinemedicine.diseasePiracetamClinical trialTreatmentNeurologyAnesthesiaAnticonvulsantsDrug Therapy CombinationFemaleObservational studyEpilepsies PartialNeurology (clinical)LevetiracetamSafetybusinessmedicine.drugSeizure
researchProduct

Oxcarbazepine does not affect the anticoagulant activity of warfarin.

1992

The possible interaction of the antiepileptic drug oxcarbazepine (OCBZ) on the anticoagulant effect of warfarin was investigated in 10 healthy male volunteers. After reaching steady-state conditions by repeated administration of warfarin, the prothrombin time (Quick value) was assessed before and after single (600 mg) and multiple dosing (450 mg twice daily in 1 week) of OCBZ. In 7 of the 10 volunteers with evaluable data, the prothrombin time was not significantly different (paired t test) from baseline either after single (p = 0.299) or repeated dosing (p = 0.333), indicating that OCBZ does not interact to any relevant extent with the hypothrombinemic effect of warfarin.

DrugAdultMalemedicine.drug_classmedia_common.quotation_subjectmedicine.medical_treatmentOxcarbazepinePharmacologymedicineHumansDrug InteractionsOxcarbazepineBlood Coagulationmedia_commonProthrombin timeChemotherapymedicine.diagnostic_testDose-Response Relationship Drugbusiness.industryAnticoagulantWarfarinDose–response relationshipAnticonvulsantCarbamazepineNeurologyAnesthesiaProthrombin TimeAnticonvulsantsNeurology (clinical)Warfarinbusinessmedicine.drugEpilepsia
researchProduct